Sinphar Tian-Li Pharmaceutical Co., Ltd.(Hangzhou) is a subsidiary of Taiwan listed company SinpharPharmaceutical Group and is the largest overseas investment of Xinghui Group. In 2001, SinpharTianli Pharmaceuticals was established in Yuhang District, Hangzhou City, Zhejiang Province under the guidelines of Xinghui's Board of Directors, "Layout Globally, Stride Globally, Develop Global Strategy and Vision".
Sinphar-Walnut Peptide Powder Protygold®
2025 New Nutrition Business, 2025 Hi&Fi Asia, Vitafoods Asia 2025
Xinghui Tianli obtained two certificates of ISO22000 and HACCP
